322 related articles for article (PubMed ID: 27151884)
41. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.
Higgins SC; Jarnicki AG; Lavelle EC; Mills KH
J Immunol; 2006 Dec; 177(11):7980-9. PubMed ID: 17114471
[TBL] [Abstract][Full Text] [Related]
42. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
[TBL] [Abstract][Full Text] [Related]
43. The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model.
Carter CR; Dagg BM; Whitmore KM; Keeble JR; Asokanathan C; Xing D; Walker KB
Cell Immunol; 2004 Jan; 227(1):51-8. PubMed ID: 15051514
[TBL] [Abstract][Full Text] [Related]
44. Outer membrane vesicles: an attractive candidate for pertussis vaccines.
Hozbor DF
Expert Rev Vaccines; 2017 Mar; 16(3):193-196. PubMed ID: 28010142
[No Abstract] [Full Text] [Related]
45. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.
da Silva Antunes R; Babor M; Carpenter C; Khalil N; Cortese M; Mentzer AJ; Seumois G; Petro CD; Purcell LA; Vijayanand P; Crotty S; Pulendran B; Peters B; Sette A
J Clin Invest; 2018 Aug; 128(9):3853-3865. PubMed ID: 29920186
[TBL] [Abstract][Full Text] [Related]
46.
Yılmaz Çolak Ç; Tefon Öztürk BE
Pathog Glob Health; 2023 Jun; 117(4):342-355. PubMed ID: 36047634
[No Abstract] [Full Text] [Related]
47. Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.
Bancroft T; Dillon MB; da Silva Antunes R; Paul S; Peters B; Crotty S; Lindestam Arlehamn CS; Sette A
Cell Immunol; 2016; 304-305():35-43. PubMed ID: 27212461
[TBL] [Abstract][Full Text] [Related]
48. Outer membrane vesicles derived from
Pschunder B; Locati L; López O; Martin Aispuro P; Zurita E; Stuible M; Durocher Y; Hozbor D
Front Immunol; 2024; 15():1387534. PubMed ID: 38650936
[TBL] [Abstract][Full Text] [Related]
49. Characterization of co-purified acellular pertussis vaccines.
Xu Y; Tan Y; Asokanathan C; Zhang S; Xing D; Wang J
Hum Vaccin Immunother; 2015; 11(2):421-7. PubMed ID: 25610957
[TBL] [Abstract][Full Text] [Related]
50. Pertussis vaccines and the challenge of inducing durable immunity.
Warfel JM; Edwards KM
Curr Opin Immunol; 2015 Aug; 35():48-54. PubMed ID: 26091979
[TBL] [Abstract][Full Text] [Related]
51. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.
Diavatopoulos DA; Edwards KM
Cold Spring Harb Perspect Biol; 2017 Dec; 9(12):. PubMed ID: 28289059
[TBL] [Abstract][Full Text] [Related]
52. Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
Nascimento IP; Dias WO; Mazzantini RP; Miyaji EN; Gamberini M; Quintilio W; Gebara VC; Cardoso DF; Ho PL; Raw I; Winter N; Gicquel B; Rappuoli R; Leite LC
Infect Immun; 2000 Sep; 68(9):4877-83. PubMed ID: 10948100
[TBL] [Abstract][Full Text] [Related]
53. A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.
Skerry CM; Mahon BP
Clin Vaccine Immunol; 2011 Feb; 18(2):187-93. PubMed ID: 21147936
[TBL] [Abstract][Full Text] [Related]
54. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
55. New Pertussis Vaccines: A Need and a Challenge.
Hozbor D
Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
[TBL] [Abstract][Full Text] [Related]
56. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
[TBL] [Abstract][Full Text] [Related]
57. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
Front Immunol; 2022; 13():838504. PubMed ID: 35211125
[TBL] [Abstract][Full Text] [Related]
58. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2012 Nov; 19(11):1879-86. PubMed ID: 23015649
[TBL] [Abstract][Full Text] [Related]
59. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
Ausiello CM; Cassone A
mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
[TBL] [Abstract][Full Text] [Related]
60. The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
Jennings-Gee J; Quataert S; Ganguly T; D'Agostino R; Deora R; Dubey P
Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29531137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
